Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Thyroid Cancer Treatment Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2025-2037.
The increasing prevalence of thyroid cancer globally, along with the growing investment in the healthcare expenditure are expected to fuel the development of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising middle-class population in the emerging economies on a global level. According to the data collected from the United Nations Department of Economic and Social Affairs, in 2020, the estimated elderly population aged above 65 accounted for 727 million and by 2050 the number is expected to get double to approximately 1,500 million.
Thyroid Cancer Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Prevalence of Thyroid Cancer
- Increasing Geriatric Population in the World
Challenges
- High Cost of Diagnosis
- Lack of Awareness in the Under-Developed and Developing Countries
Thyroid Cancer Treatment Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
Regional Scope |
|
Thyroid Cancer Treatment Segmentation
The market is segmented based on treatment type into surgery, iodine therapy, external radiotherapy, thyroxin treatment, chemotherapy, and drugs, out of which, the drug segment is anticipated to grab the largest share by the end of 2021 on account of increased approval of thyroid cancer drugs in the market. Moreover, increasing initiative by the major players to develop better drugs in the global market is also projected to contribute to the growth of the segment during the forecast period.
On the basis of cancer type, the papillary thyroid cancer segment in the global thyroid cancer treatment market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that patients has witnessed high recovery rate in papillary thyroid cancer treatment. As a result, a considerable portion of the population with papillary thyroid cancer on a global level is expected to drive the growth of the market over the forecast period.
Based on end-user, the cancer diagnostic centres segment held the largest share in the market on the back of increasing investment in research & development studies and growing concern and awareness for thyroid cancer treatment.
Our in-depth analysis of the global market includes the following segments:
|
By Treatment Type |
|
|
By Cancer Type |
|
|
By End-user |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportThyroid Cancer Treatment Industry - Regional Synopsis
Geographically, the thyroid cancer treatment market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific industry is set to dominate majority revenue share by 2037, owing to increasing elderly population, and rising investment in R&D for the innovation of new drugs and techniques for thyroid cancer treatment in the region. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the growing healthcare investment, accompanied by the presence of leading healthcare service providers, and the increasing number of cancer patients in the region. Along with this, the countries in North America such as the United States is promoting cancer care for cancer patients, which is also expected to contribute to the market growth in the region. According to the report published by the National Cancer Institute, in 2020, 1.8 million new cancer cases were registered in the United States. Such increasing rate of cancer is further expected to drive the demand for thyroid cancer treatment products in the North American countries. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global market on account of its proven success in terms of technology development and a high prevalence of cancer in the region. As per the analysis of the European Society for Medical Oncology, 2.7 million new cancer cases were registered in the European Union, with 1.3 million deaths in 2020.
Companies Dominating the Thyroid Cancer Treatment Landscape
- Sanofi S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Exelixis, Inc.
- Medtronic plc
- Eisai Co., Ltd.
- Bayer AG
- Novartis International AG
- Pfizer Inc.
- Mylan N.V.
- Bristol Myers Squibb
In the News
Author Credits: Radhika Pawar
- Report ID: 2997
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
